Actual Small-Group Health Premiums Rise 6.1%

Small-group health insurance premiums are still going up at about the same rate as before, and the enrollee count continues to fall.

A government agency that tries to protect plans with unusually sick enrollees published the numbers in a new report.

The average monthly premium increased 6.1% in 2024, to $659. The rate of increase was down, slightly, from 6.2% in 2023.

The number of enrollees fell 5.5%, to the equivalent of about 8.6 million. In 2023, small-group enrollment fell 6.9%.

The federal Center for Consumer Information and Insurance Oversight compiles the numbers for use by the Affordable Care Act commercial health insurance risk-adjustment program.

The center is the arm of the Centers for Medicare and Medicaid Services that oversees HealthCare.gov and other ACA rules and programs that affect the commercial health insurance market.

The risk-adjustment program tries to use cash from issuers with unusually healthy, low-risk enrollees to compensate issuers that end up with unusually high-risk enrollees.

At the state level, the average small-group monthly premium ranged from $445, in Mississippi, up to $1,048, in Ohio.

California had the biggest fully insured small-group market, with about 2 million enrollees.

 

Source Link

Recommended Articles

P4ESC Warns Congress Not to Tax Health Benefits

“We oppose taxing health benefits,” said Neil Trautwein, P4ESC’s Executive Director. “Policymakers will find how widely unpopular the idea will be with Americans with this type of coverage if they take this unwise step,” added Trautwein.

Read More

At Social Security, These Are the Days of the Living Dead

In multiple instances over the past few weeks, Social Security Offices have seen people come in for whom “there is no information on the record, just that they are dead.” So employees have to “resurrect” them — affirm that they’re living, so they can receive their benefits.

Read More

Out-Of-Pocket Drug Spending Hit $98B In 2024: Report

Americans spent $98 billion out of pocket on prescription drugs in 2024, marking a cumulative 25% increase over five years, according to an annual report from analytics firm IQVIA. Why it matters: Lowering prescription drug costs remains a priority for both Democrats and Republicans. The Biden administration led Congress in passing a landmark legislative package to negotiate select drug ...

Read More

Trump Signs Executive Order To Encourage U.S. Drug Manufacturing

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing. The order directs the U.S. Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square